Please provide your email address to receive an email when new articles are posted on . Patients with focal seizures who initiated first adjunctive therapy with eslicarbazepine acetate vs.

Dermocosmetics as adjunctive therapy improved skin sensitivity and reduced acne severity, especially in retinoid users, over a 12-week period. Quality of life scores increased post-treatment, with the ...

The currently available body of evidence is not strong enough to support vitamin supplementation as a treatment for dry eye ...

Addition of the antipsychotic lumateperone (Caplyta) to an existing antidepressant improved symptoms of depression in a randomized, double-blind phase III trial. Among 484 patients with major ...

Statistically significantly effects were observed as early as week 1 and maintained throughout the study. Treatment with lumateperone significantly reduced depressive symptoms in patients with major ...

Remission (MADRS total score ≤10) was seen in 65% of patients treated with lumateperone in combination with an oral antidepressant, at 6 months. The Food and Drug Administration (FDA) has approved ...

Although monotherapy is the preferred treatment for people with epilepsy, many patients require adjunctive therapy or polytherapy if their seizures do not respond to single-drug treatment. For a ...

Atypical antipsychotic adjunctive therapy to lithium or valproate is effective in treating acute mania. Although continuation of atypical antipsychotic adjunctive therapy after mania remission reduces ...

The prevalence of prostate cancer emphasizes the need for improved therapeutic options, particularly for metastatic disease. Current treatment includes medical or surgical castration, which initially ...